DMAA: Drugs Made In America Acquisition Corp. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | 13G amendment | KARPUS MANAGEMENT, INC. | 10.33% | SEC | |
| 2026-08-14 | Fell below 5% | First Trust Merger Arbitrage Fund | 3.24% | SEC | |
| 2026-08-13 | Fell below 5% | Glazer Capital, LLC | 4.12% | SEC | |
| 2026-08-13 | 13G amendment | Mizuho Financial Group, Inc. | 8.50% | SEC |
Institutional ownership (Q2 2026)
23 institutions reported holding $134.94M of Drugs Made In America Acquisition Corp. on Form 13F (39 the quarter before). 1 opened a new position and 17 sold out. Shares held by institutions: -39%.
| Largest holders | Shares | Value |
|---|---|---|
| MIZUHO SECURITIES USA LLC | 4,069,605 | $42.83M |
| Karpus Management, Inc. | 2,507,817 | $26.71M |
| Polar Asset Management Partners Inc. | 1,146,000 | $12.20M |
| WOLVERINE ASSET MANAGEMENT LLC | 832,093 | $8.86M |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 809,054 | $8.62M |
| First Trust Capital Management L.P. | 786,459 | $8.38M |
| HEIGHTS CAPITAL MANAGEMENT, INC | 648,083 | $6.90M |
| Westchester Capital Management, LLC | 581,790 | $6.20M |
| ARISTEIA CAPITAL, L.L.C. | 350,000 | $3.73M |
| SONA ASSET MANAGEMENT (US) LLC | 162,795 | $1.73M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.